Phochinenin G exhibits potential in anticancer research due to its ability to inhibit the proliferation of certain tumor cell lines. It has shown activity against lung and breast cancer cells in vitro by interfering with cell cycle progression and inducing apoptosis. Its mechanism may involve modulation of key signaling pathways such as PI3K/Akt, making it a candidate for further investigation in oncology drug development. Additionally, Phochinenin G is studied for its structural properties that could be optimized for improved bioavailability and targeted therapy.